Trials / Conditions / Myasthenic Syndromes, Congenital
Myasthenic Syndromes, Congenital
4 registered clinical trials studyying Myasthenic Syndromes, Congenital — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes NCT06630650 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes NCT02562066 | Catalyst Pharmaceuticals, Inc. | Phase 3 |
| Unknown | Ephedrine for the Treatment of Congenital Myasthenia NCT00541216 | Hadassah Medical Organization | Phase 1 / Phase 2 |
| No Longer Available | Treatment Use of 3,4-Diaminopyridine NCT01765140 | Vern C. Juel, M.D. | — |